Author:
Mathur Anurag,Loskill Peter,Shao Kaifeng,Huebsch Nathaniel,Hong SoonGweon,Marcus Sivan G.,Marks Natalie,Mandegar Mohammad,Conklin Bruce R.,Lee Luke P.,Healy Kevin E.
Publisher
Springer Science and Business Media LLC
Reference36 articles.
1. Herper, M. The Cost Of Creating A New Drug Now $5 Billion, Pushing Big Pharma To Change <
http://www.forbes.com/sites/matthewherper/2013/08/11/how-the-staggering-cost-of-inventing-new-drugs-is-shaping-the-future-of-medicine/
> (2013).
2. Mathur, A. et al. Human induced pluripotent stem cell-based microphysiological tissue models of myocardium and liver for drug development. Stem cell research & therapy 4 Suppl 1, S14 (2013).
3. Paul, S. M. et al. How to improve R&D productivity: the pharmaceutical industry's grand challenge. Nature reviews. Drug discovery 9, 203–214 (2010).
4. Scott, C. W., Peters, M. F. & Dragan, Y. P. Human induced pluripotent stem cells and their use in drug discovery for toxicity testing. Toxicol Lett 219, 49–58 (2013).
5. Chi, K. R. Revolution dawning in cardiotoxicity testing. Nature reviews. Drug discovery 12, 565–567 (2013).
Cited by
424 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献